Nurse-initiated steroids improve pediatric asthma care

Nurse-Initiated steroids improve pediatric asthma care
Nurse initiation of oral corticosteroids before physician assessment of pediatric patients with asthma improves quality and efficiency of care provided in the pediatric emergency department, according to a study published online March 19 in Pediatrics.

(HealthDay) -- Nurse initiation of oral corticosteroids before physician assessment of pediatric patients with asthma improves quality and efficiency of care provided in the pediatric emergency department, according to a study published online March 19 in Pediatrics.

Roger Zemek, M.D., from the University of Ottawa in Canada, and colleagues evaluated nurse initiation of treatment with in children with Pediatric Respiratory Assessment Measure score ≥4. One-to-one periods (physician-initiated and nurse-initiated) were analyzed. In both phases, triage nurses initiated bronchodilator therapy before physician assessment, per Pediatric Respiratory Assessment Measure score. The researchers reviewed charts of 644 consecutive children (aged 2 to 17 years) for outcomes, including admission rate; time to clinical improvement, steroid receipt, mild status, and discharge; and rate of return emergency department visit and subsequent admission.

The researchers found that children treated in the nurse-initiated phase improved significantly earlier compared with those treated in the physician-initiated phase (median difference, 24 minutes). Admission was significantly less likely if children received steroids at triage (odds ratio, 0.56). Significant efficiency gains were made in time to steroid receipt (median difference, 44 minutes), time to mild status (51 minutes), and time to discharge (44 minutes). No differences were observed in return visit rate or subsequent admission.

"Triage nurse initiation of oral corticosteroid before physician assessment was associated with reduced times to clinical improvement and discharge, and reduced admission rates in children presenting with moderate to severe acute exacerbations," the authors write.

One author disclosed financial ties to the pharmaceutical industry.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Steroids to treat asthma: How safe are they?

Feb 24, 2011

Children experiencing an asthma attack who are treated with a short burst of oral steroids may have a transient depression of immune response according to a new study led by Université de Montréal. These findings, ...

Recommended for you

A better biomonitor for children with asthma

Dec 10, 2014

For the firefighters and rescue workers conducting the rescue and cleanup operations at Ground Zero from September 2001 to May 2002, exposure to hazardous airborne particles led to a disturbing "WTC cough"—obstructed ...

New insight into risk of Ankylosing Spondylitis

Dec 09, 2014

Scientists at the University of Southampton have discovered variations in an enzyme belonging to the immune system that leaves individuals susceptible to Ankylosing Spondylitis.

Novel approach to treating asthma: Neutralize the trigger

Dec 03, 2014

Current asthma treatments can alleviate wheezing, coughing and other symptoms felt by millions of Americans every year, but they don't get to the root cause of the condition. Now, for the first time, scientists ...

Inflammatory discovery sheds new light on skin disease

Dec 02, 2014

Inflammatory skin diseases such as psoriasis may result from abnormal activation of cell death pathways previously believed to suppress inflammation, a surprise finding that could help to develop new ways ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.